2,951
Views
47
CrossRef citations to date
0
Altmetric
Original Articles: Prostate Cancer

MRI-only based radiation therapy of prostate cancer: workflow and early clinical experience

, , , , , , & show all
Pages 902-907 | Received 04 Nov 2017, Accepted 21 Feb 2018, Published online: 28 Feb 2018

References

  • Khoo V, Joon D. New developments in MRI for target volume delineation in radiotherapy. Br J Radiol. 2006;79:2–15.
  • Sciarra A, Barentsz J, Bjartell A, et al. Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol. 2011;59:962–977.
  • Dirix P, Haustermans K, Vandecaveye V. The value of magnetic resonance imaging for radiotherapy planning. Semin Radiat Oncol. 2014;24:151–159.
  • Expert Panel on Radiation Oncology-Prostate, Zaorsky NG, Showalter TN, et al. CR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II. Adv Rad Oncol. 2017;2:62–84.
  • Kapanen M, Collan J, Beule A, et al. Commissioning of MRI-only based treatment planning procedure for external beam radiotherapy of prostate. Magn Reson Med. 2013;70:127–135.
  • Korhonen J, Kapanen M, Keyriläinen J, et al. Influence of MRI-based bone outline definition errors on external radiotherapy dose calculation accuracy in heterogeneous pseudo-CT images of prostate cancer patients. Acta Oncol. 2014;53:1100–1106.
  • Mah D, Steckner M, Hanlon A, et al. MRI simulation: effect of gradient distortions on three-dimensional prostate cancer plans. Int J Radiat Oncol Biol Phys. 2002;53:757–765.
  • Chen Z, Ma C-M, Paskalev K, et al. Investigation of MR image distortion for radiotherapy treatment planning of prostate cancer. Phys Med Biol. 2006;51:1393–1403.
  • Crijns SPM, Bakker CJG, Seebinck PR, et al. Towards inherently distortion-free MR images for image-guided radiotherapy on an MRI accelerator. Phys Med Biol. 2012;57:1349–1358.
  • Torfeh T, Hammoud R, Perkins G, et al. Characterization of 3D geometric distortion of magnetic resonance imaging scanners commissioned for radiation therapy planning. Magn Reson Imaging. 2016;34:645–653.
  • Gustafsson C, Nordström F, Persson E, et al. Assessment of dosimetric impact of system specific geometric distortion in an MRI only based radiotherapy workflow for prostate. Phys Med Biol. 2017;62:2976–2989.
  • Lee Y, Bollet M, Charles-Edwards G, et al. Radiotherapy treatment planning of prostate cancer using magnetic resonance imaging alone. Radiother Oncol. 2003;66:203–216.
  • Koivula L, Kapanen M, Seppälä T, et al. Intensity-based dual model method for generation of synthetic CT images from standard T2-weighted MR images - generalized technique for four different MR scanners. Radiother Oncol. 2017;125:411–419.
  • Johansson A, Karlsson M, Nyholm T. CT substitute derived from MRI sequences with ultrashort echo time. Med Phys. 2011;38: 2708–2714.
  • Korhonen J, Kapanen M, Keyriläinen J, et al. A dual model HU conversion from MRI intensity values within and outside of bone segment for MRI-based radiotherapy treatment planning of prostate cancer. Med Phys. 2014;41:1–13.
  • Kapanen M, Tenhunen M. T1/T2*-weighted MRI provides clinically relevant pseudo-CT density data from pelvic bones in MRI-only based radiotherapy treatment planning. Acta Oncol. 2013;52: 612–618.
  • Koivula L, Wee L, Korhonen J. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images. Med Phys. 2016;43:4634–4642.
  • Edmund JM, Nyholm T. A review of substitute CT generation for MRI-only radiation therapy. Radiat Oncol. 2017;12:28.
  • Johnstone E, Wyatt JJ, Henry AM, et al. Systematic review of synthetic computed tomography generation methodologies for use in magnetic resonance imaging-only radiation therapy. Int J Radiat Oncol Biol Phys. 2018;100:199–217.
  • Korhonen J, Kapanen M, Keyriläinen J, et al. Absorbed doses behind bones with MR image-based dose calculations for radiotherapy treatment planning. Med Phys. 2013;40:1–10.
  • Korhonen J, Kapanen M, Sonke JJ, et al. Feasibility of MRI-based reference images for image-guided radiotherapy in the pelvis with either cone-beam computed tomography or planar localization images. Acta Oncol. 2014;54:1–7.
  • Seppälä T, Visapää H, Collan J, et al. Converting from CT- to MRI-only-based target definition in radiotherapy of localized prostate cancer: a comparison between two modalities. Strahlenther Onkol. 2015;191:862–868.
  • Gustafsson C, Korhonen J, Persson E, et al. Registration free automatic identification of gold fiducial markers in MRI target delineation images for prostate radiotherapy. Med Phys. 2017;44:5563–5574.
  • Ghose S, Mitra J, Rivest-hénault D, et al. MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection. Med Phys. 2016;43:2218.
  • Tyagi N, Fontenla S, Zelefsky M, et al. Clinical workflow for MR-only simulation and planning in prostate. Radiat Oncol. 2017;12:119.
  • Persson E, Gustafsson C, Nordström F, et al. MR-OPERA: a multicenter/multivendor validation of magnetic resonance imaging only prostate treatment planning using synthetic computed tomography images. Int J Radiat Oncol Biol Phys. 2017;99:692–700.
  • Dowling J, Lambert J, Parker J, et al. An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapy. Int Radiat Oncol Biol Phys. 2012;83:5–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.